Emily Anthes is a freelance science journalist and author based in Brooklyn, New York. She writes news stories for The Transmitter. Her work has also appeared in The New York Times, Wired, Nature and elsewhere. Her book, “Frankenstein’s Cat: Cuddling Up to Biotech’s Brave New Beasts,” was published in March 2013. She has a master’s degree in science writing from the Massachusetts Institute of Technology and a bachelor’s degree in the history of science and medicine from Yale.
Emily Anthes
Contributing Writer
Spectrum
From this contributor
Extra proteins alter microglia and behavior in mice
The overproduction of proteins in brain cells called microglia causes social impairments, cognitive deficits and repetitive behavior in male mice, a new study has found.
Extra proteins alter microglia and behavior in mice
By
Emily Anthes
29 May 2020 | 4 min read
Popular autism screening tool is unreliable, study suggests
A short, widely used screening survey for autism called the AQ-10 may not be reliable for measuring traits of the condition in the general population.
Popular autism screening tool is unreliable, study suggests
By
Emily Anthes
2 April 2020 | 3 min read
Little-known gene tied to autism, developmental delay
Rare mutations in a gene called BAZ2B are associated with various conditions of brain development, including autism.
Little-known gene tied to autism, developmental delay
By
Emily Anthes
28 February 2020 | 4 min read
Sponsors of clinical trials may report data late or never
Many clinical trials, including those related to autism, do not report their results within a year of their completion.
Sponsors of clinical trials may report data late or never
By
Emily Anthes
10 February 2020 | 5 min read
Autism-linked gene variants increase odds of attention deficit
A collection of rare genetic variants associated with autism and schizophrenia also seem to increase a person's odds of having attention deficit hyperactivity disorder.
Autism-linked gene variants increase odds of attention deficit
By
Emily Anthes
18 November 2019 | 4 min read
Explore more from The Transmitter
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
By
Jill Adams
21 January 2025 | 2 min read
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
By
Omar Abubaker, Karla Kaun, Eric J. Nestler
21 January 2025 | 7 min read
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
By
Carina Heller
20 January 2025 | 7 min read